Home › NDC Lookup › RxCUI directory › RxCUI 1607784

Deferasirox 180 MG Oral Tablet — RxCUI 1607784

Name: Deferasirox 180 MG Oral Tablet (RxCUI 1607784)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1607784 Semantic clinical drug · SCD ● Current RxNorm concept 42 FDA products 63 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1607784

Official nameDeferasirox 180 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped42

Package NDCs mapped63

Reported Medicaid activity (SDUD)9,139 prescriptions · 32 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Deferasirox: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

When you get a lot of blood transfusions, or when your body absorbs too much iron due to a condition like thalassemia, iron can pile up in organs like the liver and heart and cause...
What exactly is deferasirox doing in my body — and why do I need it?
It depends on which formulation you have. If you're taking Exjade (the tablet you dissolve in juice or water), take it on an empty stomach, at least 30 minutes before eating. If yo...
How should I take this — does it matter whether I eat first?

📖 Read our full Deferasirox guide →

🕸️ Concept Web — How Deferasirox 180 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Deferasirox 180 MG Oral Tablet RxCUI 1607784 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Deferasirox 614373 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Jadenu 1607785 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Deferasirox Oral Tablet 1607783 SCDF
- Deferasirox Oral Product 1157197 SCDG
- Deferasirox Pill 1607782 SCDG
- Deferasirox Oral Tablet [Jadenu] 1607787 SBDF
- Jadenu Oral Product 1607788 SBDG
- Jadenu Pill 1607789 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Deferasirox 180 MG 1607781 SCDC
- Deferasirox 180 MG Oral Tablet [Jadenu] 1607790 SBD
- Deferasirox 180 MG [Jadenu] 1607786 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Deferasirox 180 MG SCDC · 1607781
Deferasirox Oral Tablet SCDF · 1607783
Deferasirox Oral Product SCDG · 1157197
Deferasirox Pill SCDG · 1607782

Brand-Name Concepts

Deferasirox 180 MG Oral Tablet [Jadenu] SBD · 1607790
Deferasirox 180 MG [Jadenu] SBDC · 1607786
Deferasirox Oral Tablet [Jadenu] SBDF · 1607787
Jadenu Oral Product SBDG · 1607788
Jadenu Pill SBDG · 1607789
Jadenu BN · 1607785

📦 FDA Products & Package NDCs

42 products · 63 package NDCs

63 package NDCs map to RxCUI 1607784 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
70710-1276-01	100 TABLET, FILM COATED in 1 BOTTLE (70710-1276-1)	deferasirox	Zydus Pharmaceuticals USA Inc.	2020-06-16
70710-1276-03	30 TABLET, FILM COATED in 1 BOTTLE (70710-1276-3)	deferasirox	Zydus Pharmaceuticals USA Inc.	2020-06-16
70710-1277-01	100 TABLET, FILM COATED in 1 BOTTLE (70710-1277-1)	deferasirox	Zydus Pharmaceuticals USA Inc.	2019-11-21
70710-1277-03	30 TABLET, FILM COATED in 1 BOTTLE (70710-1277-3)	deferasirox	Zydus Pharmaceuticals USA Inc.	2019-11-21
70771-1471-01	100 TABLET, FILM COATED in 1 BOTTLE (70771-1471-1)	deferasirox	Zydus Lifesciences Limited	2019-11-21
70771-1471-03	30 TABLET, FILM COATED in 1 BOTTLE (70771-1471-3)	deferasirox	Zydus Lifesciences Limited	2019-11-21
70771-1472-01	100 TABLET, FILM COATED in 1 BOTTLE (70771-1472-1)	deferasirox	Zydus Lifesciences Limited	2020-06-16
70771-1472-03	30 TABLET, FILM COATED in 1 BOTTLE (70771-1472-3)	deferasirox	Zydus Lifesciences Limited	2020-06-16
70771-1473-01	100 TABLET, FILM COATED in 1 BOTTLE (70771-1473-1)	deferasirox	Zydus Lifesciences Limited	2019-11-21
70771-1473-03	30 TABLET, FILM COATED in 1 BOTTLE (70771-1473-3)	deferasirox	Zydus Lifesciences Limited	2019-11-21
72603-0231-01	30 TABLET, FILM COATED in 1 BOTTLE (72603-231-01)	DEFERASIROX	NorthStar Rx LLC	2023-10-16
72603-0232-01	30 TABLET, FILM COATED in 1 BOTTLE (72603-232-01)	DEFERASIROX	NorthStar Rx LLC	2023-10-16
72603-0233-01	30 TABLET, FILM COATED in 1 BOTTLE (72603-233-01)	DEFERASIROX	NorthStar Rx LLC	2023-10-16

Observed labelers: Alembic Pharmaceuticals Inc. (6) · Alembic Pharmaceuticals Limited (6) · Ascend Laboratories, LLC (6) · Dr. Reddy's Laboratories Inc (6) · MSN LABORATORIES PRIVATE LIMITED (6) · Novartis Pharmaceuticals Corporation (6) · +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.